Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma appoints Dr Craig Landau as its CEO

He also takes up president role

Craig Landau Purdue Pharma has appointed Dr Craig Landau as its new chief executive officer and president, roles that will see him be responsible for the firm’s US operations and retain responsibility for Purdue’s Canadian operations.

Landau first joined the Connecticut, US-based firm as president and CEO of Purdue Pharma Canada, he's spent the last three years diversifying and stabilising the business through a number of strategic business development deals.

He said: "I am honoured to be leading these organisations at such an exciting time.

"I look forward to building on Purdue’s rich history and working with my talented colleagues as we continue to broaden our portfolio and innovate to support healthcare professionals and serve patient needs.”

He succeeds Mark Timey who leaves Purdue Pharma to “pursue other career opportunities”.

29th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics